(Buffalo, NY) Cleveland BioLabs Inc. receive approval from the Russian Ministry of health to begin phase 1 clinical trials for the induction and mobilization of hematopoietic stem cells....
(Rockville, MD) MEDIPOST America Inc. announced US FDA approval of a phase 1/2 clinical trial for PNEUMOSTEM for newborn infants who will be at high risk for developing bronchopulmonary...
(London, England) After experiencing a heart attack, a patient underwent injection of his own stem cells into the damaged heart tissue to stimulate regeneration....